Bispecific Antibody Therapeutics Market Analysis, opportunities Trends and Industry Strategies 2019 – 2030
With various target combinations and novel mechanisms of action, bispecific antibodies are presently recognized as a potent class of targeted therapies, with the potential to be used as treatment options for a variety of disease indications. Several pipeline candidates have recently entered mid to late-stage (phase II and above) trials and are anticipated to enter the market over the next 5-10 years.
The USD 6.9 billion financial opportunity (by 2030) within the Bispecific Antibody Therapeutics Market has been analyzed across the following segments:
Therapeutic Area
· Autoimmune Disorders
· Eye Disorders
· Genetic Disorders
· Hematological Malignancies
· Infectious Diseases
· Inflammatory Disorders
· Skin Disorders
Mechanism of Action
· Cytokines Retargeting / Neutralization
· Dual Ligands Blocking
· T-cell Retargeting / Activation
· Others
Target Antigens
· CD3 x CD19
· CD30 x CD16A
· Factor IXa x Factor X
· IL-1α x IL-1β
· IL-13 x IL-4
· IL-17A x Albumin
· IL-17A x IL-17F
· Psl x PcrV
· VEGF-A x ANG2
· Others
Antibody Formats
· Asymmetric
· Fragments
· Symmetric
· Others
Key Geographical Regions
· North America
· Europe
· Asia-Pacific
For more information, please visit https://www.rootsanalysis.com/reports/view_document/bispecific-antibodies/286.html
The Bispecific Antibody Therapeutics Market (4th Edition), 2020-2030 report features the following companies, which we identified to be key players in this domain:
· Amgen
· Ablynx
· AbbVie
· Affibody
· Affimed
· Alphamab
· AstraZeneca
· Avillion
· Chugai Pharmaceuticals
· Eddingpharm
· GSK
· Merck
· Merus
· Roche
· Regeneron Pharmaceuticals
· Taisho Pharmaceuticals
· Zymeworks
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Market Overview
5. Bispecific Antibody Therapeutics: Technology Platforms
6. Drug Profiles
7. Key Insights
8. Benchmark Analysis: Big Pharma Players
9. Partnerships and Collaborations
10. Contract Services for Bispecific Antibody Therapeutics
11. Clinical Trial Analysis
12. Case Study: Regulatory Guidelines for Bispecific Antibodies
13. Case Study: Promotional / Marketing Strategies
14. SWOT Analysis
15. Market Forecast and Opportunity Analysis
16. Concluding Remarks
17. Executive Insights
18. Appendix 1: Tabulated Data
19. Appendix 2: List of Companies and Organizations
For more information, please click on the following link:
https://www.rootsanalysis.com/reports/view_document/bispecific-antibodies/286.html
About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415